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682a Wednesday, March 4, 2009to wildtype animals. Upon induction of hyperglycemia in knockouts, expression
of PKC d was only slightly increased to the level found in non-diabetic wild-
types. Expression, phosphorylation and translocation of PKC isoforms, how-
ever, remained unaffected by the induction of diabetes in Ga11-deficient mice.
We conclude that Ga11 is central to the induction of myocardial hypertrophy in
type 1 diabetes. Activation of PKC a and z appear to be important pathways in
hypertrophic signaling via Ga11. The inhibition of this pathway may in part
explain the strong therapeutic benefit of AT1 receptor blockade in diabetic pa-
tients.
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The responsiveness of cerebral microvasculature to stimulation by intrinsic li-
gands is altered during diabetes. Studies attribute this to a defect in endothelial
cell function. However, the etiology underlying endothelial cell dysfunction
during diabetes remains poorly characterized. Here we show that methyl-
glyoxal (MGO), a reactive carbonyl species whose production increases shortly
after the onset of hyperglycemia, impairs rat brain endothelial cell function, in
vivo and in vitro. When pial arterioles in anesthetized rats were exposed to
adenosine diphosphate (10mM) and nitroglycerin (1mM), vessel diameters in-
creased by 12.55 0.7% and 22.05 2.6%, respectively. Pre-treating arterioles
with 25mM of freshly synthesized MGO for 30 min at 370C, significantly atten-
uated the response of vessels to stimulation by adenosine diphosphate (4.65
1.1%), but the response to nitroglycerin was preserved (19.75 1.7%). In live-
cell confocal imaging employing relevant probes, acute exposure (15min) of rat
brain microvascular endothelial cells to MGO (25mM-100mM) triggered dose-
dependent increases in cytoplasmic and mitochondrial Ca2þ levels, and mito-
chondrial superoxide production. Acute exposure to MGO also reduced cyto-
plasmic nitric oxide level reminiscent of an increased cytoplasmic superoxide
production as well. Incubating rat brain microvascular endothelial cells with
MGO for 24hr at 370C MGO reduce cell viability in a dose-dependent manner
with an EC50 of 75mM. MGO treatment also reduced the viability of brain mi-
crovascular smooth muscle cells, but the EC50 was shifted rightwards to
300mM. Taken collectively, these data suggest that increased production of
MGO following early upregulation of semicarbazide-sensitive amine oxidase
(also referred to as vascular adhesion protein1) may be an initiating cause for
endothelial dysfunction during diabetes. (Work supported in part by grants
from NIH to WGM and KRB)
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Adenosine in the heart manifests an anti-adrenergic action that limits adrener-
gic stimulation of the myocardium. One mechanism involves the stimulation of
specific A1 receptors (A1R) that reduces b-adrenergic-induced Gs protein cy-
cling. This results in a reduction in adrenergic-enhanced adenylyl cyclase activ-
ity, cAMP levels, protein kinase A activation and contractile protein phosphor-
ylation. Adenosine via A1R has been reported by this laboratory to induce the
activation and translocation of PKCe to RACK2, and by others to induce phos-
phorylation and activation of p38-MAPKs. The latter exerts a negative inotro-
pic effect possibly by phosphorylating heat shock protein 27 (Hsp27), which
subsequently phosphorylates aB-crystallin resulting in a reduction in myofila-
ment Ca2þ sensitivity. The hypothesis of this study is that another mechanism
by which A1R limits contractile function involves the activation of a MAPK
cascade and the phosphorylation of Hsp27. Mouse hearts were isolated and per-
fused with physiological saline. After stabilization, agents were administered
for the designated times, whereupon hearts were freeze-clamped. Frozen heart
proteins were resolved by SDS-PAGE, transferred and blotted with antibodies
against Hsp27 and phospho-Hsp-27(Ser82). Stimulation of the heart with chlor-
ocyclopentyladenosine (CCPA, 1mM), an A1R agonist, for 5 min increased the
presence of phospho-Hsp27 by 2.6-fold, whereas treatment for 45 minutes in-
creased it by 27-fold. Furthermore, 45 min of CCPA increased the ratio of phos-
pho-Hsp27:total Hsp27 by 40-fold. Increases elicited by CCPA stimulation
were inhibited by the A1R antagonist DPCPX (0.1 mM) and by the p38-
MAPK inhibitor SB-203580 (2.64 mM). Together these data suggest that the
A1R modulates heart function by eliciting the phosphorylation of Hsp27 by
a signaling cascade involving p38-MAPK.3520-Pos Board B567
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In this study we investigated putative correlations between key proteins of the
Gq-coupled pathway and atrial arrhythmia (AA) in humans. For this purpose
we used quantitative real time PCR to investigate transcription levels of various
genes including: protein kinase C (PKC), phospholipase C and inositol-1,4,5-
trisphosphate receptor. The mRNA was isolated from human auricles obtained
from patients undergoing heart surgery that we divided into four groups:
1. patients with AA without cardio-specific medication
2. patients with AA receiving ACE- and/or beta-blocker
3. patients with sinus rhythm receiving ACE- and/or beta-blocker
4. patients with sinus rhythm without cardio-specific medication
Initial analysis of the mRNA appeared to suggest significant alterations of gene
transcription with respect to the groups (1-4). Gene transcripts that were up-reg-
ulated during disease were found to be down-regulated in patients receiving
cardio-specific medication. During atrial fibrillation structural remodeling oc-
curs. Thus we investigated whether such remodeling was also reflected in the
transcriptional activity of tissue specific marker genes. We found that e.g.
the transcriptional activity of the PKCa gene strongly correlated with markers
for endothelial cells and fibroblasts but did not show any correlation with my-
ocyte specific markers. This finding suggested that in human atria PKCa is not
expressed in the myocyte. Instead, transcriptional signals of this gene product
most likely solely originate from non-muscle cells. Results such as the one de-
scribed strongly suggest that qPCR analysis of entire cardiac tissue ought to be
interpreted in light of possible changes of the tissue composition that usually
accompanies cardiac diseases.
This work was supported by: German Science Foundation (DFG), SFB530 and
KliFor196
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Recent research demonstrates that membrane domains on the plasma mem-
brane of cells and the underlying cytoskeleton regulate subsequent receptor me-
diated signaling. However less is known about how the three dimensional
plasma membrane architecture created by proteins, lipids and cytoskeleton is
regulated by the cell itself. Influencing the architecture of the plasma membrane
by distinct signaling pathways may be one crucial mechanism for the cell to
selectively respond to external signaling stimuli. Therefore, signaling pathways
must be identified that affect its assembly.
Recently, we showed that membrane receptor and domain aggregation and their
dynamics drive bone stem cell differentiation toward osteoblastic lineage com-
mitment, however we failed to identify pathways necessary for lipid, protein
and cytoskeletal assembly. In order to identify these novel roles of classical
pathways, we employed the Family of Image Correlation Spectroscopy,
Atomic Force Microscopy followed by Fractal Analysis, roughness calcula-
tions, and molecular biology techniques to primary bone marrow stromal cells
isolated from mice; C57BL/6 (B6, control) and B6C3H-1-12 (1-12, high peak
bone density).
Our results revealed two signaling pathways that affect membrane morphology.
These signaling pathways are activated at distinct steps during osteoblast dif-
ferentiation and communication with surrounding cells. While triggering the
first signaling cascade altered the topography of the cell membrane by modify-
ing the maximum valley depth, the second pathway caused a change in the pe-
rimeter and area of distinct membrane regions. Our data suggest that osteoblast
precursor cells and osteoblasts undergo physical changes in the membrane de-
pendent on their stage of differentiation. These variations in the topography
were triggered by distinct signaling pathways causing a rearrangement of the
plasma membrane. These changes may be crucial for the response of the cells
to external stimuli received at various timeopoints during the differentiation
event.
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It is believed, but not without dispute, that activation of PKB is essential to ob-
tain cardioprotection by ischemic preconditioning (IP). Here we have investi-
gated the role of PKB activity in ischemic myocardial injury and IP using novel
specific PKB inhibitors, examined whether any effect is species-dependent and
determined its location in the transduction pathway. The specific PKB inhibi-
tors VIII (0.05, 0.5 and 5mM) and XI (0.1, 1 and 10mM) were co-incubated
with rat ventricular myocardium for 20min prior to 90min ischemia/120min re-
oxygenation at 37C (n¼6/group). CK release and cell necrosis and apoptosis
(% of nuclei) were significantly decreased by more than 60% at all concentra-
tions of both inhibitors. Similar protection was obtained with IP, results that
were unaffected by PKB inhibitors. The PI-3K inhibitors LY294002 (10mM)
and wortmanin (0.1mM) administered for 20min prior to ischemia induced
identical results to those seen with PKB inhibitors. The protection afforded
by PKB inhibitor XI was unaffected by the presumed mitoKATP channel
blocker 5-HD (10mM) but was abrogated by the p38MAPK inhibitor
SB203580 (10mM).Western Blot and Proteome Profiler studies confirmed a de-
crease in PKB phosphorylation in myocardium exposed to IP, wortmanin and
PKB inhibitor XI. Studies using human myocardium also showed that both
PKB inhibitor XI (1mM) and PI-3K inhibitor wortmanin (0.1mM) equally re-
duced CK release and cell necrosis and apoptosis. The diabetic myocardium,
that could not be protected by IP or diazoxide (100mM), was however protected
by PKB inhibitor XI and wortmanin, further suggesting that PKB is located be-
yond the mitochondria. In conclusion, inhibition of PKB activity is protective
against ischemic injury of the rat and human myocardium and is as potent as IP.
Importantly, PKB is downstream of the 5-HD target but upstream of
p38MAPK.
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We have previously characterized physiological heart hypertrophy which oc-
curs during pregnancy in mice. Hypertrophic stimuli, including volume over-
load, mechanical stretch, together with hormonal changes are potential triggers
of pregnancy-induced heart hypertrophy1. The underlying molecular mecha-
nisms of pregnancy-induced heart hypertrophy, which makes the heart work
more efficiently, are not well understood. The mechanical stretch of cardio-
myocytes can activate second messengers such as mitogen-activated protein ki-
nase (MAPK). MAPK will facilitate the phosphorylation of extracellular sig-
nal-regulated kinases (ERK), c-Jun N-terminal kinases (JNK) and P38. The
protein kinase Akt, which regulates the growth and survival of many cell types,
has been proposed to be required for physiological heart hypertrophy. Here we
performed Western Blot analysis together with high resolution confocal mi-
croscopy as to measure protein levels and subcellular distribution of cardiac
MAPKs (P38, JNK1/2, ERK1/2) and Akt in non-pregnant (NP, at diestrus
stage, as this stage has been exposed to low levels of estrogen for the longest
time) and late pregnant (LP) mice. Western Blot analysis of heart lysates
showed that only phospho-P38 protein levels were decreased ~ 2 fold at the
end of pregnancy (n¼7 NP and n¼5 LP mice). High resolution confocal mi-
croscopy showed that P38, phospho-P38, JNK1/2, phospho-JNK, ERK1/2
and phospho-ERK were distributed in discrete clusters in the cytoplasm, T-tu-
bules as well as in the nucleus, and their subcellular distribution did not change
with pregnancy (n¼3 NP and n¼3 LP mice). As expected, for a protective Akt
activity, nuclear phospho-Akt labeling was significantly higher in LP compared
to NP, forming discrete aggregates in the nuclear region.
1. Eghbali M, Deva R, Alioua A, Minosyan TY, Ruan H, Wang Y, Toro L, Ste-
fani E. Molecular and functional signature of heart hypertrophy during preg-
nancy. Circ Res. 2005;96:1208-16.
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Superoxide production from NADPH oxidases has increasingly been shown to
play an important role in myocardial signalling. The activity of myocardial
NADPH oxidases is known to be increased in the failing myocardium; how-
ever, whether this is a compensatory or maladaptive mechanism remains to
be established. Gene deletion of the neuronal nitric oxide synthase (nNOS) is
associated with an increase in myocardial superoxide production and with en-
hanced inotropy. Here we tested whether nNOS gene deletion leads to an in-crease in myocardial NADPH oxidase activity, which - in turn - causes a super-
oxide (O2
-)-dependent increase in contraction.
As expected, O2
- production (measured by lucigenin 5mmol/L -enhanced chem-
iluminescence) was greater in nNOS/ LV myocytes than in their wild type
littermates (nNOSþ/þ). Pre-incubation of LV myocytes with the NADPH oxi-
dase inhibitor apocynin (100 mmol/L, 30 min) reduced the level of O2
- in
nNOS/myocytes only, thereby abolishing the difference between genotypes.
In agreement with these findings, apocynin significantly reduced cell shorten-
ing (%, field stimulation at 3Hz, 35C) only in nNOS/ myocytes. Inhibition
of protein kinase A (amide 14-22, PKI, 2 mmol/L) reduced contraction to
a larger extent in nNOS/. The effects of PKA inhibition were abolished after
pre-incubation with apocynin. NADPH oxidase stimulation by endothelin-1
(ET-1, 10 nM, 5-10 min) caused an increase in cell shortening in both
nNOS/ and nNOSþ/þ myocytes, which was abolished by apocynin. PKI sig-
nificantly reduced the effect of ET-1 in both genotypes.
Taken together, these findings suggest that nNOS-derived NOmay tonically in-
hibit the activity of NADPH oxidase in murine LV myocytes and indicate that
production of O2
- by this oxidase system may account for the PKA-dependent
increase in cell shortening in nNOS/ mice.
3525-Pos Board B572
Activation of the Cardiac Sarcolemmal ATP-sensitive Potassium Channel
by A1 and A3 Receptor Agonists: Confirmation from knockout mice studies
Akihito Tampo, Tina C. Wan, John A. Auchampach, Wai-Meng Kwok.
Medical College of Wisconsin, Milwaukee, WI, USA.
Activation of the A1 adenosine receptor (AR) provides cardioprotection against
ischemia/reperfusion injury most likely by facilitating opening of the cardiac
sarcolemmal KATP (sarcKATP) channel. Recently, A3AR agonists have also
been reported to protect the myocardium against ischemia/reperfusion injury.
Though the functional coupling between the A1AR and sarcKATP is well docu-
mented, the coupling between the A3AR and the sarcKATP channel is unknown
due to a lack of direct evidence. In the present study, we characterized the abil-
ity of the respective AR agonists to elicit opening of the sarcKATP channel. To
activate A1 or A3AR, CPA (1mM) or CP-532,903 (1mM), respectively, were
used. Whole-cell sarcKATP channel current, IKATP, was recorded from ventric-
ular myocytes enzymatically isolated from hearts obtained from wild-type
(WT) and A1 and A3AR gene knock-out (A1KO and A3KO, respectively)
mice. In all studies, potential input from A2A and A2BARs was blocked by
the extracellular application of ZM 241385 (100nM) and PBS 663 (100nM).
In WT myocytes, CPA and CP-532,903 elicited IKATP with current densities
of 2.650.7pA/pF (mean 5 SEM, n¼6) and 2.450.7pA/pF (n¼7), respec-
tively. To confirm the effects of the respective agonists, experiments were re-
peated in A1KO and A3KO myocytes. In the A1KO myocytes, CP-532,903, but
not CPA, elicited IKATP with a current density of 2.250.4pA/pF (n¼6). This
confirmed that the activation of IKATP by CP-532,903 was via the A3AR. On
the other hand, in the A3KO myocytes, CPA, but not CP-532,903, elicited
IKATP with a current density of 2.350.7pA/pF (n¼4). These results provide
strong evidence of the functional coupling between A3AR and the sarcKATP
channel. They further confirm the specificities of the A1AR and A3AR agonists
to activate the sarcKATP channel via the A1 and A3AR, respectively.
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We recently reported that the functional coupling of c-Src with 5-HT2AR is an
early and critical step in 5-HT-induced vascular contraction and that both pro-
teins strongly associate with each other. Because the C-terminus of 5-HT2AR
can serve for signal transduction, and the N-terminal half of c-Src (residues
1-251) contains SH2 and SH3 domains known to bind associating partners,
we hypothesized that the association between 5-HT2AR and c-Src may occur
via these domains. To address whether SH2 and SH3 domains are sufficient
for c-Src interaction with 5-HT2AR, a truncated c-Src construct containing
SH2 and SH3 but lacking the kinase-regulatory domain (c-Src1-251) was
made. Coimmunoprecipitation (co-IP) showed that both wild type c-Src (c-
SrcWT) and c-Src1-251 can be pulled down by 5-HT2AR underscoring a role
for the c-Src domain containing SH2 and SH3 in 5-HT2AR-c-Src association.
Additionally, it indicates that c-Src phosphorylation activity is not essential
for c-Src and 5-HT2AR association. However, when c-SrcWT and 5-HT2AR
are co-IPed, tyrosine phosphorylation (pY) Ab recognizes a phosphorylated
protein with molecular mass identical to 5-HT2AR, which is absent when c-
Src1-251 lacking its phosphorylation catalytic domain is used. Together the
data indicate that 5-HT2AR interaction with c-Src and the c-Src-mediated
